心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2017 ACC专家共识：二尖瓣反流的管理决策路径

2017-10-17 美国心脏病学会 J Am Coll Cardiol. 2017 Oct 17.

二尖瓣反流

2017年10月，美国心脏病学会(ACC)发布了二尖瓣反流的管理共识，二尖瓣反流是一种复杂的瓣膜病变，其管理给心血管医师带来了重大挑战。本文主要涉及二尖瓣反流临床管理的相关内容，包括二尖瓣反流的病因，发病机制，患者评估以及治疗等。

中文标题：

2017 ACC专家共识：二尖瓣反流的管理决策路径

英文标题：

2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.

发布机构：

美国心脏病学会

发布日期：

2017-10-17

简要介绍：

2017年10月，美国心脏病学会(ACC)发布了二尖瓣反流的管理共识，二尖瓣反流是一种复杂的瓣膜病变，其管理给心血管医师带来了重大挑战。本文主要涉及二尖瓣反流临床管理的相关内容，包括二尖瓣反流的病因，发病机制，患者评估以及治疗等。

 

拓展指南：与二尖瓣相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 ACC专家共识：二尖瓣反流的管理决策路径)] GetToolGuiderByIdResponse(projectId=1, id=313c11c0015116bc, title=2017 ACC专家共识：二尖瓣反流的管理决策路径, enTitle=2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways., guiderFrom=J Am Coll Cardiol. 2017 Oct 17., authorId=null, author=, summary=2017年10月，美国心脏病学会(ACC)发布了二尖瓣反流的管理共识，二尖瓣反流是一种复杂的瓣膜病变，其管理给心血管医师带来了重大挑战。本文主要涉及二尖瓣反流临床管理的相关内容，包括二尖瓣反流的病因，发病机制，患者评估以及治疗等。 , cover=, journalId=null, articlesId=null, associationId=849, associationName=美国心脏病学会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Oct 17 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>2017年10月，美国心脏病学会(ACC)发布了二尖瓣反流的管理共识，二尖瓣反流是一种复杂的瓣膜病变，其管理给心血管医师带来了重大挑战。本文主要涉及二尖瓣反流临床管理的相关内容，包括二尖瓣反流的病因，发病机制，患者评估以及治疗等。 </P> <P> </P>拓展指南：<strong>与<font color=red>二尖瓣</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=c2cc41c0013618e3" title="2016 AATS共识指南：缺血性二尖瓣关闭不全（更新版）" target=_blank>2016 AATS共识指南：缺血性二尖瓣关闭不全（更新版）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=38d5d1c001332a15" title="2015 ESC立场声明：二尖瓣返流的手术和介入治疗" target=_blank>2015 ESC立场声明：二尖瓣返流的手术和介入治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=bf3991c0012888fc" title="2016 中国经皮球囊二尖瓣成形术指南" target=_blank>2016 中国经皮球囊二尖瓣成形术指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=42ae61c0010e17fb" title="2014 AATS/ACCF/SCAI/STS多学会专家共识：经导管瓣膜修复和置换操作要求与经营规范（第二部分二尖瓣）" target=_blank>2014 AATS/ACCF/SCAI/STS多学会专家共识：经导管瓣膜修复和置换操作要求与经营规范（第二部分二尖瓣）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=1d1661c00101a96b" title="2013 ANZSCTS指南：微创二尖瓣手术安全介绍" target=_blank>2013 ANZSCTS指南：微创二尖瓣手术安全介绍</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E4%BA%8C%E5%B0%96%E7%93%A3" target=_blank>有关二尖瓣更多指南</a></ul>, tagList=[TagDto(tagId=2993, tagName=二尖瓣反流)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4750, appHits=283, showAppHits=7, pcHits=3460, showPcHits=1803, likes=145, shares=9, comments=5, approvalStatus=1, publishedTime=Thu Oct 26 23:22:29 CST 2017, publishedTimeString=2017-10-17, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Oct 26 23:22:29 CST 2017, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 10:45:44 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 ACC专家共识：二尖瓣反流的管理决策路径)])
2017 ACC专家共识：二尖瓣反流的管理决策路径
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=256512, encodeId=e09d256512ef, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Oct 28 00:25:55 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256305, encodeId=ad292563051e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Oct 27 07:26:14 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256296, encodeId=97fa2562960e, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Oct 27 07:11:34 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256270, encodeId=ea4c2562e01b, content=谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Oct 27 06:33:42 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256254, encodeId=df22256254ca, content=好好好好好好的㎡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Oct 27 05:28:38 CST 2017, time=2017-10-27, status=1, ipAttribution=)]
    2017-10-28 1e0ece0dm09(暂无匿称)

    谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=256512, encodeId=e09d256512ef, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Oct 28 00:25:55 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256305, encodeId=ad292563051e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Oct 27 07:26:14 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256296, encodeId=97fa2562960e, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Oct 27 07:11:34 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256270, encodeId=ea4c2562e01b, content=谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Oct 27 06:33:42 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256254, encodeId=df22256254ca, content=好好好好好好的㎡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Oct 27 05:28:38 CST 2017, time=2017-10-27, status=1, ipAttribution=)]
    2017-10-27 Y—xianghai

    学习了新知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=256512, encodeId=e09d256512ef, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Oct 28 00:25:55 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256305, encodeId=ad292563051e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Oct 27 07:26:14 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256296, encodeId=97fa2562960e, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Oct 27 07:11:34 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256270, encodeId=ea4c2562e01b, content=谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Oct 27 06:33:42 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256254, encodeId=df22256254ca, content=好好好好好好的㎡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Oct 27 05:28:38 CST 2017, time=2017-10-27, status=1, ipAttribution=)]
    2017-10-27 明月清辉

    谢谢分享.学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=256512, encodeId=e09d256512ef, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Oct 28 00:25:55 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256305, encodeId=ad292563051e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Oct 27 07:26:14 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256296, encodeId=97fa2562960e, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Oct 27 07:11:34 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256270, encodeId=ea4c2562e01b, content=谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Oct 27 06:33:42 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256254, encodeId=df22256254ca, content=好好好好好好的㎡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Oct 27 05:28:38 CST 2017, time=2017-10-27, status=1, ipAttribution=)]
    2017-10-27 天地飞扬

    谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=256512, encodeId=e09d256512ef, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Oct 28 00:25:55 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256305, encodeId=ad292563051e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Oct 27 07:26:14 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256296, encodeId=97fa2562960e, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Oct 27 07:11:34 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256270, encodeId=ea4c2562e01b, content=谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Fri Oct 27 06:33:42 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256254, encodeId=df22256254ca, content=好好好好好好的㎡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Oct 27 05:28:38 CST 2017, time=2017-10-27, status=1, ipAttribution=)]
    2017-10-27 yjs木玉

    好好好好好好的㎡

    0